当前位置：
X-MOL 学术
›
Drug Resist. Updat.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
On the spread and control of MDR-TB epidemics: an examination of trends in anti-tuberculosis drug resistance surveillance data.
Drug Resistance Updates ( IF 15.8 ) Pub Date : 2014-10-06 , DOI: 10.1016/j.drup.2014.10.001 Ted Cohen 1 , Helen E Jenkins 2 , Chunling Lu 3 , Megan McLaughlin 4 , Katherine Floyd 5 , Matteo Zignol 5
Drug Resistance Updates ( IF 15.8 ) Pub Date : 2014-10-06 , DOI: 10.1016/j.drup.2014.10.001 Ted Cohen 1 , Helen E Jenkins 2 , Chunling Lu 3 , Megan McLaughlin 4 , Katherine Floyd 5 , Matteo Zignol 5
Affiliation
BACKGROUND
Multidrug resistant tuberculosis (MDR-TB) poses serious challenges for tuberculosis control in many settings, but trends of MDR-TB have been difficult to measure.
METHODS
We analyzed surveillance and population-representative survey data collected worldwide by the World Health Organization between 1993 and 2012. We examined setting-specific patterns associated with linear trends in the estimated per capita rate of MDR-TB among new notified TB cases to generate hypotheses about factors associated with trends in the transmission of highly drug resistant tuberculosis.
RESULTS
59 countries and 39 sub-national settings had at least three years of data, but less than 10% of the population in the WHO-designated 27-high MDR-TB burden settings were in areas with sufficient data to track trends. Among settings in which the majority of MDR-TB was autochthonous, we found 10 settings with statistically significant linear trends in per capita rates of MDR-TB among new notified TB cases. Five of these settings had declining trends (Estonia, Latvia, Macao, Hong Kong, and Portugal) ranging from decreases of 3% to 14% annually, while five had increasing trends (four individual oblasts of the Russian Federation and Botswana) ranging from 14% to 20% annually. In unadjusted analysis, better surveillance indicators and higher GDP per capita were associated with declining MDR-TB, while a higher existing absolute burden of MDR-TB was associated with an increasing trend.
CONCLUSIONS
Only a small fraction of countries in which the burden of MDR-TB is concentrated currently have sufficient surveillance data to estimate trends in drug-resistant TB. Where trend analysis was possible, smaller absolute burdens of MDR-TB and more robust surveillance systems were associated with declining per capita rates of MDR-TB among new notified cases.
更新日期：2019-11-01
京公网安备 11010802027423号